Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
Simon Faissner(St. Josef-Hospital), V. Wee Yong(University of Calgary), Manoj K. Mishra(Alabama State University), Yan Fan(Zhejiang A & F University), Luanne M. Metz(University of Calgary), Cláudia Silva(University of Calgary), Jianxiong Wang(University of Calgary), Deepak Kaushik(Memorial University of Newfoundland), Gail Rauw(University of Alberta), Marcus Koch(University of Calgary)
Cited by 65
Related Papers
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
|Nature Reviews Drug Discovery|2019|456
Cosmeceuticals: An emerging concept
|Indian Journal of Pharmacology|2005|147
Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis
|Journal of Clinical Investigation|2019|137
Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation
|Journal of Neuroinflammation|2010|103
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
|Chemical Science|2017|93